Strs Ohio Crispr Therapeutics Ag Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$110.2 - $156.64 $1.28 Million - $1.82 Million	-11,642 Closed	0 $0
Q3 2020 Dec 14, 2020	BUY	$78.5 - $100.64 $913,897 - $1.17 Million	11,642 New	11,642 $973,000
Q3 2019 Oct 21, 2019	SELL	$40.99 - $52.56 $1.33 Million - $1.7 Million	-32,406 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$22.73 - $42.34 $736,588 - $1.37 Million	32,406 New	32,406 $925,000

485

57.5M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.24B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.